1. Home
  2. EBS vs MAGN Comparison

EBS vs MAGN Comparison

Compare EBS & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • MAGN
  • Stock Information
  • Founded
  • EBS 1998
  • MAGN 1864
  • Country
  • EBS United States
  • MAGN United States
  • Employees
  • EBS N/A
  • MAGN N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • MAGN Paper
  • Sector
  • EBS Health Care
  • MAGN Basic Materials
  • Exchange
  • EBS Nasdaq
  • MAGN Nasdaq
  • Market Cap
  • EBS 423.6M
  • MAGN 416.2M
  • IPO Year
  • EBS 2006
  • MAGN N/A
  • Fundamental
  • Price
  • EBS $10.48
  • MAGN $8.81
  • Analyst Decision
  • EBS Strong Buy
  • MAGN Hold
  • Analyst Count
  • EBS 2
  • MAGN 1
  • Target Price
  • EBS $13.50
  • MAGN $12.00
  • AVG Volume (30 Days)
  • EBS 1.4M
  • MAGN 747.8K
  • Earning Date
  • EBS 10-29-2025
  • MAGN 11-20-2025
  • Dividend Yield
  • EBS N/A
  • MAGN N/A
  • EPS Growth
  • EBS N/A
  • MAGN N/A
  • EPS
  • EBS 1.35
  • MAGN N/A
  • Revenue
  • EBS $788,900,000.00
  • MAGN $2,919,000,000.00
  • Revenue This Year
  • EBS N/A
  • MAGN $49.20
  • Revenue Next Year
  • EBS $19.24
  • MAGN $5.03
  • P/E Ratio
  • EBS $7.77
  • MAGN N/A
  • Revenue Growth
  • EBS N/A
  • MAGN 34.21
  • 52 Week Low
  • EBS $4.02
  • MAGN $8.40
  • 52 Week High
  • EBS $13.41
  • MAGN $23.19
  • Technical
  • Relative Strength Index (RSI)
  • EBS 54.80
  • MAGN 36.74
  • Support Level
  • EBS $9.21
  • MAGN $9.23
  • Resistance Level
  • EBS $13.41
  • MAGN $9.11
  • Average True Range (ATR)
  • EBS 0.82
  • MAGN 0.51
  • MACD
  • EBS 0.17
  • MAGN -0.03
  • Stochastic Oscillator
  • EBS 32.84
  • MAGN 18.47

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

Share on Social Networks: